|
Companies' Sessions
|
|
|
Pfizer Session - Prostaglandins in the Eye
|
|
| |
|
Prostaglandins
in the Eye
Chairperson: W. Stewart |
Back
to
Section List page |
| |
|
| |
The efficacy and mechanism
of prostaglandin analogues
P. Kaufman
|
|
| |
|
|
| |
Persistency of treatment with
glaucoma therapy
W. Stewart
|
|
| |
|
|
 |
When monotherapy is not enough
J. Thygeson
|
|
| |
|
|
Pfizer Session - Update on Age-Related Macular Degeneration
Treatment
Chairperson: A. Adamis |
|
| |
|
|
| |
Update of age-related macular
degeneration treatment: the role of vascular endothelial
growth factor (VEGF)
A. Adamis
|
|
| |
Update on age-related macular
degeneration treatment: macugen efficacy data
E.S. Gragoudas
|
|
| |
|
|
